Search Results

The 12 lead glove is designed to configure ECG electrodes in a single unit using a conventional ECG electrode configuration for the purpose of conducting an electrocardiogram. It is for use in patients with a chest girth of 97 - 104 cm.

The 12 lead glove is designed to configure ECG electrodes in a single unit using a conventional ECG electrode configuration for the purpose of conducting an electrocardiogram.

I am sorry, but the provided text from the FDA 510(k) letter does not contain the specific information required to answer your questions regarding the acceptance criteria, study details, and performance of the "12 Lead Glove" device.

The document is a clearance letter indicating that the device has been found substantially equivalent to a predicate device, allowing it to be legally marketed. It specifies the trade/device name, regulatory number, regulation name, regulatory class, product code, and the date of the 510(k) submission and review. It also includes the "Indications for Use" for the device, which states:

"The 12 lead glove is designed to configure ECG electrodes in a single unit using a conventional ECG electrode configuration for the purpose of conducting an electrocardiogram. It is for use in patients with a chest girth of 97 - 104 cm."

However, it does not include:

1. A table of acceptance criteria and reported device performance.
2. Sample sizes used for test sets or data provenance.
3. Number of experts, their qualifications, or adjudication methods for ground truth.
4. Information on multi-reader multi-case (MRMC) comparative effectiveness studies.
5. Details on standalone algorithm performance.
6. The type of ground truth used in studies.
7. Sample size or ground truth establishment for the training set.

To obtain this information, you would typically need to refer to the full 510(k) submission document, which would contain the clinical or non-clinical testing data that the FDA reviewed to make its substantial equivalence determination. This letter is merely the outcome of that review.

Ask a specific question about this device

The 12 lead glove is designed to configure ECG electrodes in a single unit using a conventional ECG electrode configuration for the purpose of conducting an electrocardiogram. It is for use in patients with a chest girth of 97 - 104 cm.

The 12-Lead Glove has been designed to obtain an electrocardiogram (ECG) with pre-positioned electrodes affixed to the underside of a glove-like sheath. The pre-printed conductive circuity is contained within the sheath (or shell) on a flexible substrate. To obtain the tracing, the operator need only connect the glove via a single (multi-conductor) cable connected to the ECC monitor, slip on the glove, position their hand on the patient's chest, and attach three extendable electrodes which will provide a full 12-Lead recording. The 12-Lead Glove saves valuable time required for set-up compared to the standard approach with multiple electrode placements. It eliminates the confusion of working with the standard cables and eliminates erroneous ECG readings.

Unfortunately, the provided document, the "IneedMD - ILC Dover 12-Lead Glove 510(k) Summary," primarily focuses on the device's description, component materials, and regulatory clearance (510(k)) based on substantial equivalence to predicate devices. It does not contain details about acceptance criteria or a study proving the device meets specific performance criteria, which would typically include performance metrics like sensitivity, specificity, accuracy, or details about clinical trials.

The document states: "We have reviewed your Section 510(k) premarket notification of intent to market the device we have reviewed your becamed the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate for use stated in the encreativent of the enactment date of the Medical Device Amendments, or to conninered proc to May 20, 1978, 11:15 devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, de rices that have been require approval of a premarket approval application (PMA)." This indicates the device received clearance based on demonstrating equivalence to existing devices, rather than through a study specifically designed to establish and meet novel acceptance criteria for its performance.

Therefore, I cannot extract the requested information (points 1-9) from the provided text, as it is not present. The summary focuses on material biocompatibility and comparison to predicate device materials, not clinical performance metrics.

Ask a specific question about this device